110 related articles for article (PubMed ID: 15887962)
1. Early absorption and distribution analysis of antitumor and anti-AIDS drugs: lipid membrane and plasma protein interactions.
Cimitan S; Lindgren MT; Bertucci C; Danielson UH
J Med Chem; 2005 May; 48(10):3536-46. PubMed ID: 15887962
[TBL] [Abstract][Full Text] [Related]
2. Binding of anti-HIV drugs to human serum albumin.
Bocedi A; Notaril S; Narciso P; Bolli A; Fasano M; Ascenzi P
IUBMB Life; 2004 Oct; 56(10):609-14. PubMed ID: 15814459
[TBL] [Abstract][Full Text] [Related]
3. Characterization of drug-protein binding process by employing equilibrium sampling through hollow-fiber supported liquid membrane and Bjerrum and Scatchard plots.
Barri T; Trtić-Petrović T; Karlsson M; Jönsson JA
J Pharm Biomed Anal; 2008 Sep; 48(1):49-56. PubMed ID: 18565712
[TBL] [Abstract][Full Text] [Related]
4. Characterization of basic drug-human serum protein interactions by capillary electrophoresis.
Martínez-Gómez MA; Sagrado S; Villanueva-Camañas RM; Medina-Hernández MJ
Electrophoresis; 2006 Sep; 27(17):3410-9. PubMed ID: 16944456
[TBL] [Abstract][Full Text] [Related]
5. Biosensor-based screening and characterization of HIV-1 inhibitor interactions with Sap 1, Sap 2, and Sap 3 from Candida albicans.
Backman D; Monod M; Danielson UH
J Biomol Screen; 2006 Mar; 11(2):165-75. PubMed ID: 16418316
[TBL] [Abstract][Full Text] [Related]
6. Allosteric modulation of anti-HIV drug and ferric heme binding to human serum albumin.
Bocedi A; Notari S; Menegatti E; Fanali G; Fasano M; Ascenzi P
FEBS J; 2005 Dec; 272(24):6287-96. PubMed ID: 16336266
[TBL] [Abstract][Full Text] [Related]
7. Quantification of interactions between drug leads and serum proteins by use of "binding efficiency".
Gustafsson SS; Vrang L; Terelius Y; Danielson UH
Anal Biochem; 2011 Feb; 409(2):163-75. PubMed ID: 21036137
[TBL] [Abstract][Full Text] [Related]
8. Approach for reliable evaluation of drug proteins interactions using surface plasmon resonance technology.
Sandblad P; Arnell R; Samuelsson J; Fornstedt T
Anal Chem; 2009 May; 81(9):3551-9. PubMed ID: 19338267
[TBL] [Abstract][Full Text] [Related]
9. Stereospecific recognition of a spirosuccinimide type aldose reductase inhibitor (AS-3201) by plasma proteins: a significant role of specific binding by serum albumin in the improved potency and stability.
Kurono M; Fujii A; Murata M; Fujitani B; Negoro T
Biochem Pharmacol; 2006 Jan; 71(3):338-53. PubMed ID: 16324683
[TBL] [Abstract][Full Text] [Related]
10. Surface plasmon resonance in protein-membrane interactions.
Besenicar M; Macek P; Lakey JH; Anderluh G
Chem Phys Lipids; 2006 Jun; 141(1-2):169-78. PubMed ID: 16584720
[TBL] [Abstract][Full Text] [Related]
11. Association studies of aggregated aqueous lutein diphosphate with human serum albumin and alpha1-acid glycoprotein in vitro: evidence from circular dichroism and electronic absorption spectroscopy.
Zsila F; Nadolski G; Lockwood SF
Bioorg Med Chem Lett; 2006 Jul; 16(14):3797-801. PubMed ID: 16678417
[TBL] [Abstract][Full Text] [Related]
12. Interaction of daunomycin antibiotic with human serum albumin: investigation by resonant mirror biosensor technique, fluorescence spectroscopy and molecular modeling methods.
Tang K; Qin YM; Lin AH; Hu X; Zou GL
J Pharm Biomed Anal; 2005 Sep; 39(3-4):404-10. PubMed ID: 15964731
[TBL] [Abstract][Full Text] [Related]
13. Screening of compounds interacting with HIV-1 proteinase using optical biosensor technology.
Markgren PO; Hämäläinen M; Danielson UH
Anal Biochem; 1998 Dec; 265(2):340-50. PubMed ID: 9882412
[TBL] [Abstract][Full Text] [Related]
14. Kinetic analysis of the interaction between amphotericin B and human serum albumin using surface plasmon resonance and fluorescence spectroscopy.
Zhou B; Li R; Zhang Y; Liu Y
Photochem Photobiol Sci; 2008 Apr; 7(4):453-9. PubMed ID: 18385888
[TBL] [Abstract][Full Text] [Related]
15. Characterization of nelfinavir binding to plasma proteins and the lack of drug displacement interactions.
Motoya T; Thevanayagam LN; Blaschke TF; Au S; Stone JA; Jayewardene AL; Chi J; Aweeka FT
HIV Med; 2006 Mar; 7(2):122-8. PubMed ID: 16420257
[TBL] [Abstract][Full Text] [Related]
16. Experimental validation of a fragment library for lead discovery using SPR biosensor technology.
Elinder M; Geitmann M; Gossas T; Källblad P; Winquist J; Nordström H; Hämäläinen M; Danielson UH
J Biomol Screen; 2011 Jan; 16(1):15-25. PubMed ID: 21149860
[TBL] [Abstract][Full Text] [Related]
17. Real-time protein biosensor arrays based on surface plasmon resonance differential phase imaging.
Wong CL; Ho HP; Suen YK; Kong SK; Chen QL; Yuan W; Wu SY
Biosens Bioelectron; 2008 Dec; 24(4):606-12. PubMed ID: 18644712
[TBL] [Abstract][Full Text] [Related]
18. Anomalous relationship between free drug fraction and its total concentration in drug-protein systems II. Binding of different ligands to plasma proteins.
Dawidowicz AL; Kobielski M; Pieniadz J
Eur J Pharm Sci; 2008 Sep; 35(1-2):136-41. PubMed ID: 18644440
[TBL] [Abstract][Full Text] [Related]
19. O2-binding albumin thin films: solid membranes of poly(ethylene glycol)-conjugated human serum albumin incorporating iron porphyrin.
Nakagawa A; Komatsu T; Huang Y; Lu G; Tsuchida E
Bioconjug Chem; 2007; 18(5):1673-7. PubMed ID: 17696490
[TBL] [Abstract][Full Text] [Related]
20. Human serum albumin supported lipid patterns for the targeted recognition of microspheres coated by membrane based on ss-DNA hybridization.
Zhang X; He Q; Cui Y; Duan L; Li J
Biochem Biophys Res Commun; 2006 Oct; 349(3):920-4. PubMed ID: 16970910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
